EUVIMEDEUVIMED entdecken
Crossref

Urease-driven nanomotors loaded with sorafenib for magnetically-guided accumulation and deep tissue penetration towards hepatocellular carcinoma therapy via ferroptosis induction

Changxing Hua, Zeyi Lu, Wenjing Cui, Wei Ren, Yi Xu, Jinglin Li, Xudong Zhao, Shiyong Zhao, Pengcheng Kang, Yunfu Cui

Microchimica Acta · 2026

DOI: 10.1007/s00604-025-07759-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microchimica Acta, 2026. Verfasst von Changxing Hua und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China. Hauptthemen laut MEDLINE: Sorafenib, Liver Neoplasms, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Beijing Xisike Clinical Oncology Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), accounting for 75-85% of liver cancers, faces limited therapeutic efficacy due to late-stage diagnosis, high malignancy, and poor drug permeability. Sorafenib (SF), a first-line multi-kinase inhibitor for unresectable HCC, suffers from low tumor-targeting efficiency and adverse effects. This study proposes a urease-driven nanomotor system (CUNMs + SF) to enhance SF delivery and tumor penetration. The nanomotors utilize porous magnetic silica nanoparticles (PMSNs) loaded with SF and modified with cyclodextrin-urease hybrids. This design enables magnetic targeting to HCC sites and autonomous propulsion via urea-fueled enzymatic conversion, overcoming physiological barriers in the tumor microenvironment.The system exhibits pH-responsive drug release (triggered at pH < 6.5) and induces ferroptosis in HCC cells by inhibiting the SLC7A13/GSH/GPX4 pathway, effectively suppressing tumor growth. In vitro and in vivo experiments demonstrate superior tumor accumulation, deep tissue penetration, and enhanced therapeutic outcomes compared to conventional SF. This work pioneers the application of enzyme-powered nanomotors in HCC therapy, addressing the limitations of systemic drug delivery while leveraging tumor-specific biochemical cues. The findings highlight the potential of biohybrid nanomotors for targeted cancer treatment and inspire future developments in stimuli-responsive nanomedicine for challenging malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibLiver NeoplasmsCarcinoma, HepatocellularAntineoplastic AgentsUreaseFerroptosisHumansAnimalsSilicon DioxideMiceDrug LiberationDrug CarriersCell Line, TumorMagnetite Nanoparticles

Stichwörter der Autor:innen

FerroptosisHepatocellular carcinomaMagnetic silica nanoparticlesNanomotorsSorafenibUrease

Substanzen

SorafenibAntineoplastic AgentsUreaseSilicon DioxideDrug CarriersMagnetite Nanoparticles

Autor:innen und Institutionen

  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China.
  • Postgraduate Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China.
  • The second Department of General Surgery, Second Hospital of Harbin, Harbin, Heilongjiang, 150056, China.
  • Department of Hepatopancreatobiliary Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China.
  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China. kang_pengcheng@126.com.
  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150086, China. yfcui7@163.com.

Förderung

  • Beijing Xisike Clinical Oncology Research Foundation

Zitieren

APA

Hua, C., Lu, Z., Cui, W., Ren, W., Xu, Y., Li, J., Zhao, X., Zhao, S., Kang, P., & Cui, Y. (2026). Urease-driven nanomotors loaded with sorafenib for magnetically-guided accumulation and deep tissue penetration towards hepatocellular carcinoma therapy via ferroptosis induction. Microchimica Acta. https://doi.org/10.1007/s00604-025-07759-w

Vancouver

Hua C, Lu Z, Cui W, Ren W, Xu Y, Li J, et al. Urease-driven nanomotors loaded with sorafenib for magnetically-guided accumulation and deep tissue penetration towards hepatocellular carcinoma therapy via ferroptosis induction. Microchimica Acta. 2026. doi:10.1007/s00604-025-07759-w

BibTeX
@article{Hua2026,
  author = {Hua, Changxing and Lu, Zeyi and Cui, Wenjing and Ren, Wei and Xu, Yi and Li, Jinglin and Zhao, Xudong and Zhao, Shiyong and Kang, Pengcheng and Cui, Yunfu},
  title = {Urease-driven nanomotors loaded with sorafenib for magnetically-guided accumulation and deep tissue penetration towards hepatocellular carcinoma therapy via ferroptosis induction},
  journal = {Microchimica Acta},
  year = {2026},
  doi = {10.1007/s00604-025-07759-w}
}
Kostenlos starten →